EUVIMEDEUVIMED entdecken
Crossref

Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2

Yongzheng Yao, Chang Liu, Fei Pei, Changqiang Zhang, Xiaoqing Cao iD

Respirology · 2025

DOI: 10.1111/resp.70078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respirology, 2025. Verfasst von Yongzheng Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Miyun District Hospital, Beijing, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Major Science and Technology Special Project of Lhasa in 2025, Tibet Autonomous Region Natural Science Foundation Group-based Assisted Medicine Project for Tibet, Beijing Tongzhou District Canal Talent Project (2020-2025).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective The role of perioperative radiotherapy in squamous cell lung cancer patients with pathologic N2 remains unclear. The purpose of this study was to explore the effectiveness of preoperative radiotherapy (PRRT) and postoperative radiotherapy (PORT) on survival.

Methods

Patients with pathologic N2 stage III squamous cell lung cancer who received PRRT combined with preoperative systemic therapy (PRST) or PORT combined with postoperative systemic therapy (POST) were identified in the Surveillance, Epidemiology, and End Results database from 2000 through 2021. Propensity score matching (PSM) was used for the matching of patients (1:1 ratio). Overall survival (OS) was compared among the different groups by using Kaplan–Meier analysis.

Results

A total of 2132 patients were included and 344 patients were excluded. After PSM, 105 patients received PRST combined with PRRT while 105 patients received PRST alone; 446 patients received POST combined with PORT while 446 patients received POST alone. For PRST combined with/without PRRT, median OS for radiotherapy was 80 months (95% confidence interval [CI], 60 to 121), which was significantly longer than that without radiotherapy (40 months [95% CI, 30 to 70]; p = 0.016); and the hazard ratio for radiotherapy was 0.65 (95% CI, 0.46 to 0.92) compared with no radiotherapy. For POST combined with/without PORT, there was no significant difference between radiotherapy and no radiotherapy for median OS (34 months [95% CI, 30 to 42] for radiotherapy versus 41 months [95% CI, 34 to 51] for no radiotherapy; p = 0.17).

Conclusion

Our results revealed that PRST combined with PRRT significantly improved OS. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Squamous CellHumansMaleFemaleAgedMiddle AgedRetrospective StudiesNeoplasm StagingRadiotherapy, AdjuvantSEER ProgramTreatment OutcomePropensity ScoreSurvival Rate

Stichwörter der Autor:innen

postoperative radiotherapypreoperative radiotherapysquamous cell lung cancer

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Miyun District Hospital, Beijing, China.
  • Department of General Medicine, Eastern Medical District of Chinese PLA General Hospital, Beijing, China.
  • Department of Oncology, Miyun District Hospital, Beijing, China.
  • Pulmonary and Critical Care Medicine Ward, Miyun District Hospital, Beijing, China.
  • Department of Thyroid, Breast, Hernia and Thoracic Surgery, Lhasa People's Hospital, Lhasa, Tibet Autonomous Region, China.
  • Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.

ORCID-Profile: Xiaoqing Cao

Förderung

  • Major Science and Technology Special Project of Lhasa in 2025
  • Tibet Autonomous Region Natural Science Foundation Group-based Assisted Medicine Project for Tibet
  • Beijing Tongzhou District Canal Talent Project (2020-2025)

Zitieren

APA

Yao, Y., Liu, C., Pei, F., Zhang, C., & Cao, X. (2025). Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2. Respirology. https://doi.org/10.1111/resp.70078

Vancouver

Yao Y, Liu C, Pei F, Zhang C, Cao X. Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2. Respirology. 2025. doi:10.1111/resp.70078

BibTeX
@article{Yao2025,
  author = {Yao, Yongzheng and Liu, Chang and Pei, Fei and Zhang, Changqiang and Cao, Xiaoqing},
  title = {Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2},
  journal = {Respirology},
  year = {2025},
  doi = {10.1111/resp.70078}
}
Kostenlos starten →